CytoNiche Biotech

CytoNiche Biotech Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from CytoNiche Biotech, Biotechnology company, 1 FUSIONOPOLIS LINK #06-06, NEXUS@ONE-NORTH, Singapore.

CytoNiche™ revolutionizes CGT manufacturing with 3D FloTrix™ technology, offering GMP-grade dissolvable microcarriers, serum-free media for MSCs, and GMP-compliant equipment to support expansion, harvesting, processing, and filling.

The conversation around the future of cell therapy continues in Singapore.This September, meet the CytoNiche Biotech tea...
11/08/2026

The conversation around the future of cell therapy continues in Singapore.

This September, meet the CytoNiche Biotech team at the ISCT Asia Regional Meeting 2026 and explore how our 3D FloTrix™ technology platform is supporting the next generation of cell therapy and exosome manufacturing.

📅 2–4 September 2026
📍 Suntec Singapore Convention & Exhibition Centre
📍 Booth 14

Visit Booth 14 to see our 3D FloTrix™ equipment firsthand, connect with our experts, and learn how our integrated solutions can support every stage of your manufacturing workflow—from cell expansion and downstream processing to automated fill-finish.

Whether you're scaling up, optimising your process, or preparing for clinical and commercial manufacturing, we'd love to discuss how CytoNiche can support your goals.

See you at Booth 14!

This year's National Day theme, "Majulah Singapura, Go Beyond!", is more than a celebration—it's a reminder that progres...
09/08/2026

This year's National Day theme, "Majulah Singapura, Go Beyond!", is more than a celebration—it's a reminder that progress begins with the courage to redefine what's possible.

At CytoNiche, this belief is at the heart of our mission: advancing global access to cell technologies through disruptive and scalable manufacturing innovations.

Singapore has built its reputation by transforming bold ideas into global impact through innovation, collaboration, and a commitment to excellence. As we celebrate the nation's 61st birthday, we're proud to be part of this vibrant biomedical ecosystem, working alongside researchers, clinicians, and industry partners to advance the future of cell manufacturing.

Inspired by this same spirit, we are committed to enabling more efficient, scalable, and accessible cell manufacturing—supporting researchers and industry partners worldwide while helping lead a new era of cell industrialisation.

As Singapore continues to go beyond, so will we—pushing the boundaries of innovation, strengthening global collaboration, and shaping the future of regenerative medicine.

Happy National Day, Singapore!

07/08/2026

Can a single stressed cell influence the quality of an entire exosome batch?

It may sound surprising, but even a small population of stressed or senescent cells can alter the extracellular vesicles being produced, affecting their composition, biological function, and potentially their therapeutic performance.

In Episode 3 of our educational series, we explore how necrotic cores, mechanical stress, and senescence-associated signalling can shape exosome quality—often long before conventional quality control detects any issues.

Discover why monitoring cell state throughout the culture process is becoming just as important as evaluating the final exosome product.

📄 Read the full article here: https://en.cytoniche.com/notes_detail/26.html

05/08/2026

Not all MSC-derived exosomes are created equal.

While mesenchymal stem cells may share common characteristics, their tissue source, passage number, and donor condition can significantly influence the composition, function, and therapeutic potential of the exosomes they produce.

In this second episode, we explore why these three variables matter—and why understanding them is essential for developing consistent, high-quality exosome products.

🎥 Watch now to discover:
🔹 How tissue source influences exosome composition
🔹 Why cell passage affects therapeutic potency
🔹 The impact of donor variability on exosome function

📄 Read the full article here: https://en.cytoniche.com/notes_detail/26.html

03/08/2026

Can high-quality exosomes be produced from low-quality cells?

As the exosome field matures, the conversation is shifting from simply producing exosomes to producing exosomes with consistent quality, defined critical quality attributes, and reliable therapeutic potential. Increasingly, researchers are recognising that the answer lies upstream—with the quality of the parent mesenchymal stem cells (MSCs).

🎥 In Episode 1 of our educational series, we explore why exosome quality starts with cell quality, how upstream variability shapes downstream outcomes, and why this understanding is essential for advancing exosome therapeutics towards clinical translation.

Watch now and stay tuned for the next episode, where we'll examine how tissue source, donor condition, and cell passage influence exosome quality.

📄 Read the full article here: https://en.cytoniche.com/notes_detail/26.html

High-quality exosomes start with high-quality MSCs.As regulatory expectations continue to evolve, the focus of MSC-EV ma...
31/07/2026

High-quality exosomes start with high-quality MSCs.

As regulatory expectations continue to evolve, the focus of MSC-EV manufacturing is shifting from simply increasing yield to establishing robust upstream process control that ensures consistent product quality.

In our latest article, we examine how MSC quality influences exosome critical quality attributes (CQAs), compare the quality control capabilities of major manufacturing platforms, and discuss how emerging regulatory guidance is reshaping the future of exosome biomanufacturing.

At CytoNiche, we believe that advancing MSC-EV therapeutics requires not only innovative technologies, but also a deeper understanding of the scientific principles that underpin product quality.

📄 Read the full article here: https://en.cytoniche.com/notes_detail/26.html

Looking for more efficient ways to advance your cell therapy manufacturing process?Let's connect at ACTO 2026.CytoNiche ...
29/07/2026

Looking for more efficient ways to advance your cell therapy manufacturing process?

Let's connect at ACTO 2026.

CytoNiche Biotech will be at Booth 23, showcasing innovative solutions designed to simplify scale-up, enhance process consistency, and support the next generation of cell therapy manufacturing.

If stem cells, NK cells, exosomes, automation, or GMP manufacturing are on your agenda, make sure to stop by and say hello.

📅 26–28 August 2026
📍 Booth 4 | Hotel Borobudur, Jakarta

See you at ACTO 2026! 🚀

27/07/2026

Your microcarrier supplier today could determine your commercial success tomorrow.
When cell therapies reach commercialisation, supply chain stability becomes critical.

Microcarriers are no longer just lab materials — they become strategic manufacturing components that affect production timelines, regulatory consistency, and patient access.

Choosing the right supplier means asking three key questions:
Can they scale?
Do they have strong change control?
Will they support you long term?

Because selecting a microcarrier supplier isn’t just a technical decision — it’s a strategic one.

📄 Read the full article here: https://en.cytoniche.com/notes_detail/25.html

24/07/2026

When a microcarrier dissolves in the bioreactor, the key regulatory question begins:

Where does that material go?

In cell therapy manufacturing, heavy purification steps are often not possible. That means the safety of raw materials, degradation products, and potential residues becomes critically important.

In this video, we explore how degradable microcarriers are evaluated—from material composition and residue testing to toxicological safety limits.

Safety is not just a statement.
It requires complete evidence, scientific validation, and regulatory alignment.

📄 Read the full article here: https://en.cytoniche.com/notes_detail/25.html
🔔 Subscribe to our channel for more insights into next-generation cell therapy and biotech innovation.

Join CytoNiche Biotech at KSSCR 2026!Discover our one-stop solutions for scalable cell manufacturing, spanning upstream ...
22/07/2026

Join CytoNiche Biotech at KSSCR 2026!

Discover our one-stop solutions for scalable cell manufacturing, spanning upstream cell culture and expansion to downstream processing, filling, and formulation. Whether you're advancing stem cell research, cell & gene therapy, extracellular vesicles (EVs), vaccines, or protein therapeutics, our integrated platform is designed to support your journey from process development to manufacturing.

Don't miss these featured technologies:
🔹 3D TableTrix™ Microcarriers – Dissolvable, high-quality 3D cell expansion
🔹 3D FloTrix™ microSPIN Multiplex System – High-throughput, parallel cell processing
🔹 3D FloTrix™ miniSPIN FLEX System – Flexible benchtop cell processing
🔹 3D FloTrix™ vivaFILL Filling System – Automated aseptic filling for cell therapy

📍 Booth A26
📅 20–21 August 2026
📌 Swiss Grand Hotel Convention Centre, Seoul, South Korea

Our team will be on hand to discuss how CytoNiche's innovative technologies can help streamline your cell manufacturing workflow. We look forward to connecting with researchers, clinicians, industry professionals, and partners from across Korea and beyond.

See you at KSSCR 2026!

Address

1 FUSIONOPOLIS LINK #06-06, NEXUS@ONE-NORTH
Singapore
138542

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Friday 09:00 - 18:00

Website

Alerts

Be the first to know and let us send you an email when CytoNiche Biotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CytoNiche Biotech:

Shortcuts

Share

Category